1. Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev 2016;29:487–524.
2. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016;374:1552–1563.
3. de Oliveira WK, de França GVA, Carmo EH, Duncan BB, de Souza Kuchenbecker R, Schmidt MI. Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis. Lancet 2017;390:861–870.
4. Krow-Lucal ER, de Andrade MR, Cananéa JNA, et al. Association and birth prevalence of microcephaly attributable to Zika virus infection among infants in Paraíba, Brazil, in 2015-16: a case-control study. Lancet Child Adolesc Health 2018;2:205–213.
5. Grubaugh ND, Ishtiaq F, Setoh YX, Ko AI. Misperceived risks of Zika-related microcephaly in India. Trends Microbiol 2019;27:381–383.
6. Liu ZY, Shi WF, Qin CF. The evolution of Zika virus from Asia to the Americas. Nat Rev Microbiol 2019;17:131–139.
7. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952;46:509–520.
8. Faria NR, Azevedo RDSDS, Kraemer MUG, et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 2016;352:345–349.
9. Weaver SC, Costa F, Garcia-Blanco MA, et al. Zika virus: history, emergence, biology, and prospects for control. Antiviral Res 2016;130:69–80.
10. Heang V, Yasuda CY, Sovann L, et al. Zika virus infection, Cambodia, 2010. Emerg Infect Dis 2012;18:349–351.
11. Duffy MR, Chen T-H, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009;360:2536–2543.
12. Musso D, Bossin H, Mallet HP, et al. Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak. Lancet Infect Dis 2018;18(5):e172–e182.
13. Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. An update on Zika virus infection. Lancet 2017;390:2099–2109.
14. Rossi SL, Ebel GD, Shan C, Shi P-Y, Vasilakis N. Did Zika virus mutate to cause severe outbreaks? Trends Microbiol 2018;26:877–885.
15. Rodriguez-Barraquer I, Costa F, Nascimento EJM, et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science 2019;363:607–610.
16. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387:1531–1539.
17. Dos Santos T, Rodriguez A, Almiron M, et al. Zika virus and the Guillain–Barré Syndrome — case series from seven countries. N Engl J Med 2016;375:1598–1601.
18. Brasil P, Pereira JP Jr, Moreira ME, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016;375:2321–2334.
19. de Araújo TVB, Rodrigues LC, de Alencar Ximenes RA, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis 2016;16:1356–1363.
20. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects — reviewing the evidence for causality. N Engl J Med 2016;374:1981–1987.
21. Pan American Health Organization. Zika cases and congenital syndrome associated with Zika virus reported by countries and territories in the Americas, 2015–2018: cumulative cases as of 5 January 2018 (https://www.paho.org/hq/index.php?option=com_content&view=article&id=12390:zika-cumulative-cases&Itemid=42090&lang=en).
22. Victora CG, Schuler-Faccini L, Matijasevich A, Ribeiro E, Pessoa A, Barros FC. Microcephaly in Brazil: how to interpret reported numbers? Lancet 2016;387:621–624.
23. Hill SC, Vasconcelos J, Neto Z, et al. Emergence of the Zika virus Asian lineage in Angola. bioRxiv. January 18, 2019 (https://www.biorxiv.org/content/10.1101/520437v1).
24. Hay JA, Nouvellet P, Donnelly CA, Riley S. Potential inconsistencies in Zika surveillance data and our understanding of risk during pregnancy. PLoS Negl Trop Dis 2018;12(12):e0006991–e0006991.
25. Liu Y, Liu J, Du S, et al. Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 2017;545:482–486.
26. Yuan L, Huang XY, Liu ZY, et al. A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science 2017;358:933–936.
27. Swanstrom JA, Plante JA, Plante KS, et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. MBio 2016;7(4):e01123-16–e01123-16.
28. Bardina SV, Bunduc P, Tripathi S, et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 2017;356:175–180.
29. Gordon A, Gresh L, Ojeda S, et al. Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua. PLoS Med 2019;16(1):e1002726–e1002726.
30. Ferguson NM, Cucunubá ZM, Dorigatti I, et al. Epidemiology: countering the Zika epidemic in Latin America. Science 2016;353:353–354.
31. Musso D, Rodriguez-Morales AJ, Levi JE, Cao-Lormeau V-M, Gubler DJ. Unexpected outbreaks of arbovirus infections: lessons learned from the Pacific and tropical America. Lancet Infect Dis 2018;18(11):e355–e361.
32. Grubaugh ND, Saraf S, Gangavarapu K, et al. Travel surveillance and genomics uncover a hidden Zika outbreak during the waning epidemic. Cell 2019;178(5):1057–1071.e11.
33. Favoretto SR, Araujo DB, Duarte NFH, et al. Zika virus in peridomestic neotropical primates, northeast Brazil. Ecohealth 2019;16:61–69.
34. Wongsurawat T, Athipanyasilp N, Jenjaroenpun P, et al. Case of microcephaly after congenital infection with Asian lineage Zika virus, Thailand. Emerging Infect Dis 2018;24:1758–1761.
35. Duong V, Dussart P, Buchy P. Zika virus in Asia. Int J Infect Dis 2017;54:121–128.
36. Gutiérrez-Bugallo G, Piedra LA, Rodriguez M, et al. Vector-borne transmission and evolution of Zika virus. Nat Ecol Evol 2019;3:561–569.
37. Kraemer MUG, Reiner RC Jr, Brady OJ, et al. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat Microbiol 2019;4:854–863.
38. Bloch EM, Ness PM, Tobian AAR, Sugarman J. Revisiting blood safety practices given emerging data about Zika virus. N Engl J Med 2018;378:1837–1841.
39. Polen KD, Gilboa SM, Hills S, et al. Update: interim guidance for preconception counseling and prevention of sexual transmission of Zika virus for men with possible Zika virus exposure — United States, August 2018. MMWR Morb Mortal Wkly Rep 2018;67:868–871.
40. Wilder-Smith A, Chang CR, Leong WY. Zika in travellers 1947–2017: a systematic review. J Travel Med 2018;25(1):tay044–tay044.
41. Mead PS, Duggal NK, Hook SA, et al. Zika virus shedding in semen of symptomatic infected men. N Engl J Med 2018;378:1377–1385.
42. Joguet G, Mansuy J-M, Matusali G, et al. Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study. Lancet Infect Dis 2017;17:1200–1208.
43. Hoen B, Schaub B, Funk AL, et al. Pregnancy outcomes after ZIKV infection in French territories in the Americas. N Engl J Med 2018;378:985–994.
44. Shapiro-Mendoza CK, Rice ME, Galang RR, et al. Pregnancy outcomes after maternal Zika virus infection during pregnancy — U.S. territories, January 1, 2016–April 25, 2017. MMWR Morb Mortal Wkly Rep 2017;66:615–621.
45. Reynolds MR, Jones AM, Petersen EE, et al. Vital signs: update on Zika virus–associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure — U.S. Zika Pregnancy Registry, 2016. MMWR Morb Mortal Wkly Rep 2017;66:366–373.
46. Pomar L, Vouga M, Lambert V, et al. Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana. BMJ 2018;363:k4431–k4431.
47. Mann TZ, Haddad LB, Williams TR, et al. Breast milk transmission of flaviviruses in the context of Zika virus: a systematic review. Paediatr Perinat Epidemiol 2018;32:358–368.
48. Miner JJ, Diamond MS. Zika virus pathogenesis and tissue tropism. Cell Host Microbe 2017;21:134–142.
49. Mier-Y-Teran-Romero L, Delorey MJ, Sejvar JJ, Johansson MA. Guillain-Barré syndrome risk among individuals infected with Zika virus: a multi-country assessment. BMC Med 2018;16:67–67.
50. Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE. Post-Campylobacter Guillain Barré syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel influenza A (H1N1) vaccination campaign. Epidemiol Infect 2018;146:1740–1745.
51. Muñoz LS, Parra B, Pardo CA. Neurological implications of Zika virus infection in adults. J Infect Dis 2017;216:Suppl 10:S897–S905.
52. Dirlikov E, Major CG, Medina NA, et al. Clinical features of Guillain-Barré syndrome with vs without Zika virus infection, Puerto Rico, 2016. JAMA Neurol 2018;75:1089–1097.
53. Costa F, Sarno M, Khouri R, et al. Emergence of congenital Zika syndrome: viewpoint from the front lines. Ann Intern Med 2016;164:689–691.
54. Miranda-Filho D de B, Martelli CM, Ximenes RA, et al. Initial description of the presumed congenital Zika syndrome. Am J Public Health 2016;106:598–600.
55. Moore CA, Staples JE, Dobyns WB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr 2017;171:288–295.
56. Honein MA, Dawson AL, Petersen EE, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017;317:59–68.
57. Rice ME, Galang RR, Roth NM, et al. Vital signs: Zika-associated birth defects and neurodevelopmental abnormalities possibly associated with congenital Zika virus infection — U.S. territories and freely associated states, 2018. MMWR Morb Mortal Wkly Rep 2018;67:858–867.
58. Ventura CV, Ventura LO. Ophthalmologic manifestations associated with Zika virus infection. Pediatrics 2018;141:Suppl 2:S161–S166.
59. van der Linden V, Pessoa A, Dobyns W, et al. Description of 13 infants born during October 2015–January 2016 with congenital Zika virus infection without microcephaly at Birth — Brazil. MMWR Morb Mortal Wkly Rep 2016;65:1343–1348.
60. Centers for Disease Control and Prevention. Overview of Zika virus testing: guidance for U.S. laboratories testing for Zika virus infection. July 24, 2017 (https://www.cdc.gov/zika/laboratories/lab-guidance.html).
61. Adebanjo T, Godfred-Cato S, Viens L, et al. Update: interim guidance for the diagnosis, evaluation, and management of infants with possible congenital Zika virus infection — United States, October 2017. MMWR Morb Mortal Wkly Rep 2017;66:1089–1099.
62. Assessment and management of Guillain-Barré syndrome in the context of Zika virus infection: interim guidance update 18 August 2016. Geneva: World Health Organization, 2016.
63. Paz-Bailey G, Rosenberg ES, Doyle K, et al. Persistence of Zika virus in body fluids — final report. N Engl J Med 2017;379:1234–1243.
64. Schaub B, Vouga M, Najioullah F, et al. Analysis of blood from Zika virus-infected fetuses: a prospective case series. Lancet Infect Dis 2017;17:520–527.
65. Pereira JP Jr, Maykin MM, Vasconcelos Z, et al. The role of amniocentesis in the diagnosis of congenital Zika syndrome. Clin Infect Dis 2019 January 8 (Epub ahead of print).
66. Schaub B, Gueneret M, Jolivet E, et al. Ultrasound imaging for identification of cerebral damage in congenital Zika virus syndrome: a case series. Lancet Child Adolesc Health 2017;1:45–55.
67. Masmejan S, Baud D, Musso D, Panchaud A. Zika virus, vaccines, and antiviral strategies. Expert Rev Anti Infect Ther 2018;16:471–483.
68. Mosquito (vector) control emergency response and preparedness for Zika virus. Geneva: World Health Organization, March 18, 2016 (http://www.who.int/neglected_diseases/news/mosquito_vector_control_response/en/).
69. Prevention of sexual transmission of Zika virus: interim guidance update. Geneva: World Health Organization, September 6, 2016 (https://apps.who.int/iris/bitstream/handle/10665/204421/WHO_ZIKV_MOC_16.1_eng.pdf?sequence=1&isAllowed=y).
70. Wilder-Smith A, Vannice K, Durbin A, et al. Zika vaccines and therapeutics: landscape analysis and challenges ahead. BMC Med 2018;16:84–84.
71. Vannice KS, Cassetti MC, Eisinger RW, et al. Demonstrating vaccine effectiveness during a waning epidemic: a WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates. Vaccine 2019;37:863–868.
72. Morain SR, Wootton SH, Eppes C. A devastating delay — Zika and the implementation gap. N Engl J Med 2017;377:1505–1507.
73. Aiken AR, Scott JG, Gomperts R, Trussell J, Worrell M, Aiken CE. Requests for abortion in Latin America related to concern about Zika virus exposure. N Engl J Med 2016;375:396–398.
74. Castro MC, Han QC, Carvalho LR, Victora CG, França GVA. Implications of Zika virus and congenital Zika syndrome for the number of live births in Brazil. Proc Natl Acad Sci U S A 2018;115:6177–6182.
75. von Seidlein L, Kekulé AS, Strickman D. Novel vector control approaches: the future for prevention of Zika virus transmission? PLoS Med 2017;14(1):e1002219–e1002219.